Rustin Howard
Director, Chairman of Nominating and Corporate
Audit Committee
Calmare Therapeutics
United States of America
Biography
Mr. Howard has over 25 years of experience in technology and hi-growth business development and has served on several boards and advisory councils for business and charitable organizations. He is principal of Whitesand Investments LLC, an angel investment organization that operates as a traditional venture fund. In 1990, he founded and served as CEO and Chairman of Phyton, Inc., a world leader in the use of proprietary plant cell fermentation technology, including the production of paclitaxel, the active ingredient of Bristol-Myers Squibb's multi-billion dollar anticancer drug, Taxol®. Phyton was sold to DFB Pharmaceuticals, Inc. in 2003.
Research Interest
cell fermentation technology, the production of paclitaxel, Entrepreneurship, and managing innovation and technology.
